サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1291477

HPV検査およびパップテスト市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

HPV Testing and PAP Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 143 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
HPV検査およびパップテスト市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要：

世界のHPV検査およびパップテストの市場規模は、2022年に40億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に5.92%の成長率（CAGR）を示し、2028年までに56億米ドルに達すると予測しています。

ヒトパピローマウイルス（HPV）は、子宮頸部、口腔咽頭、陰茎、外陰部のがんを引き起こす性感染症（STI）です。HPVやパップテスト（パップテスト）など、さまざまな検査や処置の支援を受けて検出することができます。これらの評価は、検体の顕微鏡観察と子宮頸がん、頭頸がん、頸部がんのスクリーニングで構成されています。このうち、HPV検査は、性器いぼの発生に先立つヒトパピローマウイルスの存在を評価するために展開され、一方、パップテストは、細胞内の変化や子宮頸部の異常細胞の存在を判定するために使用されます。

HPV検査およびパップテストの市場動向：

パピローマウイルスの存在により、特に成人層で子宮頸がんの有病率が増加していることが、斬新で技術的に進んだ、費用対効果の高いHPVおよびPAPスクリーニングのニーズを促進しており、これが市場成長を促す主な要因の1つとなっています。これに伴い、HPVに感染したがんを早期に発見し、治療効果をモニターするための機械支援型、血漿および無細胞デオキシリボ核酸（DNA）スクリーニングの導入も、成長を促す要因として作用しています。さらに、コロナウイルス感染症（COVID-19）のパンデミックの突然の発生を理由に、使いやすい家庭用HPVスクリーニング検査など、主なプレーヤーによる継続的な臨床試験、開発、製品の発売が、市場における競争力を高めていることも、これを裏付けています。その他、ヘルスケア分野の急速な拡大や、子宮頸がんの原因やHPV検査・パップテストを受けることの利点について人々を啓発するために政府機関や非政府組織（NGO）が行っている数々の好ましい取り組みなどが、市場に明るい展望をもたらしています。

本レポートで回答した主な質問

  • 世界のHPV検査およびパップテスト市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界のHPV検査およびパップテスト市場に与えた影響は？
  • 主要な地域市場とは？
  • 検査タイプに基づく市場の内訳は？
  • 製品に基づく市場の内訳は？
  • アプリケーションに基づく市場の内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々なステージは何か？
  • 業界における主要な促進要因と課題は何か？
  • 世界のHPV検査およびパップテスト市場の構造と主要プレイヤーは？
  • 業界の競合の程度はどの程度か？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な業界動向

第5章 世界のHPV検査およびパップテスト市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 検査タイプ別市場内訳

  • HPV検査
    • 市場動向
    • 市場予測
  • パップテスト
    • 市場動向
    • 市場予測
  • 併用検査
    • 市場動向
    • 市場予測

第7章 製品別市場内訳

  • 機器
    • 市場動向
    • 市場予測
  • 消耗品
    • 市場動向
    • 市場予測
  • サービス
    • 市場動向
    • 市場予測

第8章 アプリケーション別市場内訳

  • 子宮頸がん検診
    • 市場動向
    • 市場予測
  • 膣がん検診
    • 市場動向
    • 市場予測

第9章 エンドユーザー別市場内訳

  • 病院・診療所
    • 市場動向
    • 市場予測
  • ラボラトリー
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会（Opportunities
  • 脅威（Treats

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Arbor Vita Corporation
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Biocon Limited
    • bioMerieux SA
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Hologic Inc.
    • NURX Inc.（Thirty Madison Inc.）
    • Qiagen N.V.
    • Quest Diagnostics Incorporated
    • Seegene Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: HPV Testing and PAP Test Market: Major Drivers and Challenges
  • Figure 2: Global: HPV Testing and PAP Test Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: HPV Testing and PAP Test Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: HPV Testing and PAP Test Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: HPV Testing and PAP Test Market: Breakup by Product (in %), 2022
  • Figure 6: Global: HPV Testing and PAP Test Market: Breakup by Application (in %), 2022
  • Figure 7: Global: HPV Testing and PAP Test Market: Breakup by End User (in %), 2022
  • Figure 8: Global: HPV Testing and PAP Test Market: Breakup by Region (in %), 2022
  • Figure 9: Global: HPV Testing and PAP Test (HPV Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: HPV Testing and PAP Test (HPV Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: HPV Testing and PAP Test (Pap Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: HPV Testing and PAP Test (Pap Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: HPV Testing and PAP Test (Co-testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: HPV Testing and PAP Test (Co-testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: HPV Testing and PAP Test (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: HPV Testing and PAP Test (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: HPV Testing and PAP Test (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: HPV Testing and PAP Test (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: HPV Testing and PAP Test (Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: HPV Testing and PAP Test (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: HPV Testing and PAP Test (Cervical Cancer Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: HPV Testing and PAP Test (Vaginal Cancer Screening) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: HPV Testing and PAP Test (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: HPV Testing and PAP Test (Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: HPV Testing and PAP Test (Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: HPV Testing and PAP Test (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: HPV Testing and PAP Test (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: HPV Testing and PAP Test (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: HPV Testing and PAP Test (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: HPV Testing and PAP Test Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: HPV Testing and PAP Test Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: HPV Testing and PAP Test Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: HPV Testing and PAP Test Industry: SWOT Analysis
  • Figure 83: Global: HPV Testing and PAP Test Industry: Value Chain Analysis
  • Figure 84: Global: HPV Testing and PAP Test Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: HPV Testing and PAP Test Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: HPV Testing and PAP Test Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: HPV Testing and PAP Test Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 4: Global: HPV Testing and PAP Test Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: HPV Testing and PAP Test Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: HPV Testing and PAP Test Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: HPV Testing and PAP Test Market: Competitive Structure
  • Table 8: Global: HPV Testing and PAP Test Market: Key Players
目次
Product Code: SR112023A5889

Market Overview:

The global HPV testing and PAP test market size reached US$ 4.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 5.6 Billion by 2028, exhibiting a growth rate (CAGR) of 5.92% during 2023-2028. 

Human papillomavirus (HPV) is a sexually transmitted infection (STI) that causes cancer of the cervix, oropharynx, penis, and vulva. It can be detected with the support of various tests and procedures, such as HPV and Papanicolaou (PAP) test. These assessments comprise microscopic observation of specimens and cervical, head and neck cancer screening. Amongst these, HPV tests are deployed for assessing the presence of human papillomavirus that precede the development of genital warts, whereas PAP tests are used for determining changes in the cell and the presence of abnormal cells in cervices. 

HPV Testing and PAP Test Market Trends:

The increasing prevalence of cervical cancer, especially amongst the adult demographics. due to presence of papillomavirus is facilitating the need for novel, technologically advanced, and cost-effective HPV and PAP screening, which is one of the major factors primarily driving the market growth. In line with this, the introduction of machine-assisted, plasma- and cell-free deoxyribonucleic acid (DNA) screenings to detect and monitor the treatment response of HPV-infected cancers at the early phase is acting as another growth-inducing factor. This is further supported by the continuous clinical trials, developments, and product launches by key players, such as the easy-to-use home HPV screening test, on account of the sudden outbreak of coronavirus disease (COVID-19) pandemic, is providing them with a competitive edge in the market. Other factors, such as the rapid expansion in the healthcare sector and the numerous favorable initiatives undertaken by the government bodies and the non-governmental organizations (NGOs) for sensitizing people regarding the causes of cervical cancer and the benefits of having HPV and PAP tests are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global HPV testing and PAP test market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, product, application and end user.

Breakup by Test Type:

  • HPV Test
  • Pap Test
  • Co-testing

Breakup by Product:

  • Instruments
  • Consumables
  • Services

Breakup by Application:

  • Cervical Cancer Screening
  • Vaginal Cancer Screening

Breakup by End User:

  • Hospitals and Clinics
  • Laboratories
  • Diagnostic Centers
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, AstraZeneca plc, Becton Dickinson and Company, Biocon Limited, bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., NURX Inc. (Thirty Madison Inc.), Qiagen N.V., Quest Diagnostics Incorporated, Seegene Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global HPV testing and PAP test market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global HPV testing and PAP test market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global HPV testing and PAP test market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global HPV Testing and PAP Test Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Test Type

  • 6.1  HPV Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Pap Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Co-testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7   Market Breakup by Product

  • 7.1  Instruments
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Consumables
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Services
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8   Market Breakup by Application

  • 8.1  Cervical Cancer Screening
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Vaginal Cancer Screening
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by End User

  • 9.1  Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Diagnostic Centers
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2  Arbor Vita Corporation
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  AstraZeneca plc
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4  Becton Dickinson and Company
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Biocon Limited
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  bioMerieux SA
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8  F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9  Hologic Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  NURX Inc. (Thirty Madison Inc.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11  Qiagen N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12  Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
    • 15.3.13  Seegene Inc.
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
    • 15.3.14  Thermo Fisher Scientific Inc.
      • 15.3.14.1 Company Overview
      • 15.3.14.2 Product Portfolio
      • 15.3.14.3 Financials
      • 15.3.14.4 SWOT Analysis